Clinical Trial

CPG RADAR LAUNCHES AI-DRIVEN PLATFORM TO UPLEVEL R&D AND EXPEDITE INNOVATION FOR CPG STAKEHOLDERS

New Platform Analyzes Millions of Data Points from Nutrition Products, Ingredients and Clinical Science to Provide Competitive Insights in Real…

1 year ago

Experts ensure that early detection and proper prevention are key to tackling the future challenges of cancer

Before the start of the ESMO congress, MEDSIR has brought together scientists, researchers, pharmaceutical companies, and patient association representatives to…

1 year ago

CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

Preliminary immunogenicity results demonstrate induction of cancer antigen-specific T-cell responses in 77% of evaluable patients following CVGBM monotherapy84% of immune…

1 year ago

Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024

SEATTLE WA and LUND, SWEDEN / ACCESSWIRE / September 13, 2024 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB…

1 year ago

Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

- New CFO Brings Multiple Years of Experience from Biotech Companies- As Part of the New Hire, the Company Issues…

1 year ago

Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines

BOSTON, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing…

1 year ago

Aetion Announces Leadership Changes

Kevin Riley, industry leader with global experience in technology commercialization, joins as presidentCarolyn Magill steps down as CEO; Jeremy Rassen,…

1 year ago

ESMO 2024: Stay Informed with Real-Time Coverage and Analysis from DelveInsight

As the stage is set for another year of groundbreaking research and transformative treatment advancements, several companies are seizing the…

1 year ago

MIE2024 Conference article shows material data quality improvement and time savings in clinical trial data capture with nCartes

FREMONT, Calif., Sept. 12, 2024 /PRNewswire/ -- The 34th Medical Informatics Europe Conference was held in Athens, Greece August 25-29, 2024.…

1 year ago

PhaseV Unveils Machine Learning-Powered Platform to Improve Oncology Clinical Trials

Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments BOSTON, Sept. 12, 2024 /PRNewswire/ --…

1 year ago